228 filings
8-K
LXRX
Lexicon Pharmaceuticals Inc
10 May 24
Unregistered Sales of Equity Securities
4:15pm
8-K
LXRX
Lexicon Pharmaceuticals Inc
2 May 24
Lexicon Pharmaceuticals Reports First Quarter 2024
4:07pm
8-K
LXRX
Lexicon Pharmaceuticals Inc
29 Apr 24
Departure of Directors or Certain Officers
9:00am
8-K
LXRX
Lexicon Pharmaceuticals Inc
12 Mar 24
Material Modifications to Rights of Security Holders
4:31pm
8-K
LXRX
Lexicon Pharmaceuticals Inc
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
0b393s
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
8-K
bccecn n8c8r
29 Dec 23
Entry into a Material Definitive Agreement
4:04pm
8-K
fhsd2yw
8 Nov 23
Lexicon Pharmaceuticals Reports Third Quarter 2023
7:22am
8-K
sycn u0d2
11 Oct 23
Departure of Directors or Certain Officers
4:06pm
8-K
4ksnbayj
3 Aug 23
Lexicon Pharmaceuticals Reports Second Quarter 2023
4:08pm
8-K
b611z
31 Jul 23
Lexicon Elects Diane E. Sullivan to Board of Directors
4:02pm
8-K
7ncv0317
24 Jul 23
Departure of Directors or Certain Officers
4:01pm
8-K
a5pklxfgrekkoi tr5
28 Jun 23
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:20pm
8-K
5be0y1dugx0js 68
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
8-K
n1cu5djzzmgl lt
31 May 23
Lexicon Announces Proposed Public Offering of Common Stock
4:17pm
8-K/A
atwb9s
8 May 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
wioq47elazq4ji
2 May 23
Entry into a Material Definitive Agreement
4:05pm
8-K
mkgon
2 May 23
Lexicon Pharmaceuticals Reports First Quarter 2023
4:03pm
8-K
vbqzkvp3s tbzcr
27 Apr 23
Entry into a Material Definitive Agreement
12:00am
8-K
bo4 qk7txefetobyr3m
2 Mar 23
Lexicon Pharmaceuticals Reports Fourth Quarter 2022
4:04pm